758 related articles for article (PubMed ID: 18328841)
21. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA
J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999
[TBL] [Abstract][Full Text] [Related]
22. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
[TBL] [Abstract][Full Text] [Related]
24. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
Fajt M; Petrov A
Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
[TBL] [Abstract][Full Text] [Related]
25. Early aspirin desensitization in unstable patients with acute coronary syndrome: Short and long-term efficacy and safety.
Córdoba-Soriano JG; Corbí-Pascual M; López-Neyra I; Navarro-Cuartero J; Hidalgo-Olivares V; Barrionuevo-Sánchez MI; Prieto-Mateos D; Gutiérrez-Díez A; Gallardo-López A; Fuentes-Manso R; Gómez-Pérez A; Lafuente-Gormaz C; Jiménez-Mazuecos J
Eur Heart J Acute Cardiovasc Care; 2016 Nov; 5(7):41-50. PubMed ID: 26589727
[TBL] [Abstract][Full Text] [Related]
26. Noncardiac surgery and bleeding after percutaneous coronary intervention.
To AC; Armstrong G; Zeng I; Webster MW
Circ Cardiovasc Interv; 2009 Jun; 2(3):213-21. PubMed ID: 20031718
[TBL] [Abstract][Full Text] [Related]
27. Increased incidence of in-stent thrombosis related to cocaine use: case series and review of literature.
Singh S; Arora R; Khraisat A; Handa K; Bahekar A; Trivedi A; Khosla S
J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):298-303. PubMed ID: 18172224
[TBL] [Abstract][Full Text] [Related]
28. A high maintenance dose of clopidogrel improves short-term clinical outcomes in patients with acute coronary syndrome undergoing drug-eluting stent implantation.
Han YL; Wang B; Li Y; Xu K; Wang SL; Jing QM; Wang ZL; Wang DM; Ma YY; Wang G
Chin Med J (Engl); 2009 Apr; 122(7):793-7. PubMed ID: 19493391
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B
Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927
[TBL] [Abstract][Full Text] [Related]
30. Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction.
Pierre-Louis B; Aronow WS; Palaniswamy C; Singh T; Ahn C; Asija A; Weiss MB; Kalapatapu K; Pucillo AL; Monsen CE
Am J Cardiol; 2009 Jun; 103(12):1672-4. PubMed ID: 19539074
[TBL] [Abstract][Full Text] [Related]
31. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
[TBL] [Abstract][Full Text] [Related]
32. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
33. Aspirin sensitivity and coronary artery disease: implications for the practicing cardiologist.
Pattanaik D; Lieberman P; Das P
Future Cardiol; 2012 Jul; 8(4):555-62. PubMed ID: 22871195
[TBL] [Abstract][Full Text] [Related]
34. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
Hamirani YS; Jibrin I; Abraham D; Merriman B; Wenz C; Bahr RD
Crit Pathw Cardiol; 2008 Dec; 7(4):232-8. PubMed ID: 19050419
[TBL] [Abstract][Full Text] [Related]
35. [Efficacy of stenting for selective unprotected left main coronary artery disease: two-year follow-up of 416 patients].
Han YL; Wang SL; Jing QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1109-12. PubMed ID: 17672992
[TBL] [Abstract][Full Text] [Related]
36. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
Yan BP; Gurvitch R; Ajani AE
Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
[TBL] [Abstract][Full Text] [Related]
37. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy.
Pride YB; Wiviott SD; Buros JL; Zorkun C; Tariq MU; Antman EM; Braunwald E; Gibson CM;
Am Heart J; 2009 Sep; 158(3):e21-6. PubMed ID: 19699846
[TBL] [Abstract][Full Text] [Related]
38. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
[TBL] [Abstract][Full Text] [Related]
39. Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents.
Uchida Y; Mori F; Ogawa H; Takagi A; Hagiwara N
J Cardiol; 2010 May; 55(3):362-9. PubMed ID: 20350510
[TBL] [Abstract][Full Text] [Related]
40. Management of clopidogrel hypersensitivity without drug interruption.
Campbell KL; Cohn JR; Fischman DL; Walinsky P; Mallya R; Jaffrani W; Savage MP
Am J Cardiol; 2011 Mar; 107(6):812-6. PubMed ID: 21247516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
